Product Comparison

Comparison Options

• Print
• Email

McKesson #	795986	330568	842097
Description	Prevnar 13® Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free 2.2 mcg - 4.4 mcg / 0.5 mL Injection 0.5 mL	Pneumovax® 23 Pneumococcal 23 Vaccine Polyvalent 25 mcg / 0.5 mL Injection 0.5 mL	Prevnar 13® Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free 2.2 mcg - 4.4 mcg / 0.5 mL Injection 0.5 mL
Manufacturer #	00005197102	00006494300	00005197105
Brand	Prevnar 13®	Pneumovax® 23	Prevnar 13®
Manufacturer	Pfizer (RSV Vaccines)	Merck	Pfizer (RSV Vaccines)
Invoice	PREVNAR 13, SYR 0.5ML (10/CT) 9WYETH	PNEUMOVAX, SDV 25MCG/0.5ML 0.5ML (10/PK)	PREVNAR 13, SYR 0.5ML 9PFIZ
	Log In to Order	Log In to Order	Log In to Order
Comparison
Alternate Manufacturer Number	1614650		2021178
Container Type	Prefilled Syringe	Single-Dose Vial	Prefilled Syringe
Country of Origin	Unknown	United States	Unknown
Generic Drug Code	28232	14287	28232
Generic Drug Name	Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free	Pneumococcal 23 Vaccine Polyvalent	Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free
NDC Number	00005197102	00006494300	00005197105
Strength	2.2 mcg - 4.4 mcg / 0.5 mL	25 mcg / 0.5 mL	2.2 mcg - 4.4 mcg / 0.5 mL
Type	Intramuscular	Intramuscular or Subcutaneous	Intramuscular
User	Indicated for People 6 Weeks to 5 Years of Age and for People 50 Years of Age and Older	Indicated for People 50 Years of Age and Older	Indicated for People 6 Weeks to 5 Years of Age and for People 50 Years of Age and Older
Application	Pneumonia Vaccine	Pneumonia Vaccine	Pneumonia Vaccine
Dosage Form	Injection	Injection	Injection
Product Dating	McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 180 days
Storage Requirements	Requires Refrigeration	Requires Refrigeration	Requires Refrigeration
UNSPSC Code	51201615	51201615	51201615
Volume	0.5 mL	0.5 mL	0.5 mL
Features and Benefits	In children 6 weeks through 5 years of age, Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F In children Prevnar is also indicated for active immunization for the prevention of otitis media caused by Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F No otitis media efficacy data are available for serotypes 1, 3, 5, 6A, 7F, and 19A In children 6 years through 17 years of age Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F In adults 50 and older, Prevnar 13 is indicated for the active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F The tip cap and rubber plunger of the prefilled syringe do not contain latex Store Refrigerated at 2° to 8°C (36° to 46°F)	PNEUMOVAX 23 is supplied as a single-dose vial of liquid vaccine, in a box of 10 single dose vials, color coded with a purple cap and stripe on the vial labels and cartons No dilution or reconstitution is necessary PNEUMOVAX 23 is approved for use in persons 50 years of age or older and persons aged ≥2 years who are at increased risk for pneumococcal disease	In children 6 weeks through 5 years of age, Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F In children Prevnar is also indicated for active immunization for the prevention of otitis media caused by Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F No otitis media efficacy data are available for serotypes 1, 3, 5, 6A, 7F, and 19A In children 6 years through 17 years of age Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F In adults 50 and older, Prevnar 13 is indicated for the active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F The tip cap and rubber plunger of the prefilled syringe do not contain latex Store Refrigerated at 2° to 8°C (36° to 46°F)